Indikationer for radioimmunterapi til patienter med non-Hodgkins lymfom

Medicine and Dentistry

• Radioimmunotherapy 100%
• Non-Hodgkin Lymphoma 100%
• Patient with Non-Hodgkins Lymphoma 100%
• Ibritumomab Tiuxetan 66%
• Systematic Review 33%
• Clinical Trial 33%
• Radioisotope 33%
• B Lymphocyte 33%
• Stem Cell Therapy 33%
• Treatment Indication 33%
• Yttrium 90 33%

Keyphrases

• Radioimmunotherapy 100%
• Non-Hodgkin Lymphoma 100%
• 90Y-ibritumomab Tiuxetan 50%
• Clinical Trials 25%
• Throwing 25%
• B Lymphocytes 25%
• Stem Cell Transplantation 25%
• Cluster of Differentiation 25%
• Treatment Indication 25%
• Radioisotopes 25%
• Yttrium-90 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Nonhodgkin Lymphoma 100%
• Ibritumomab Tiuxetan 50%
• Clinical Trial 25%
• Radioisotope 25%
• Yttrium 90 25%